Your shopping cart is currently empty

Exo1 is an inhibitor of the exocytic pathway

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $38 | In Stock | In Stock | |
| 25 mg | $78 | In Stock | In Stock | |
| 50 mg | $139 | In Stock | In Stock | |
| 100 mg | $197 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | In Stock | In Stock |
| Description | Exo1 is an inhibitor of the exocytic pathway |
| In vitro | Exo1 functions as a modifier of Golgi ARF1 GTPase activity, offering a unique approach to modulate Golgi function. Unlike agents like BFA, Exo1 targets a specific subset of membrane processes associated with the Golgi, presumably interacting with a different protein target, which could lead to distinct side effects. It disrupts vesicular traffic between the Endoplasmic Reticulum (ER) and the Golgi apparatus by altering Golgi structures, effectively inhibiting exocytosis with an IC50 value of approximately 20 μM. Furthermore, Exo1 impedes the acquisition of endoglycosidase H resistance in newly synthesized proteins, including VSVGts-GFP, transferrin, and MHC class I[1], indicative of its role in the intricate regulation of protein trafficking and modification. |
| Molecular Weight | 273.26 |
| Formula | C15H12FNO3 |
| Cas No. | 75541-83-2 |
| Smiles | COC(=O)c1ccccc1NC(=O)c1ccc(F)cc1 |
| Relative Density. | 1.298 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 22.5 mg/mL (82.34 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 2 mg/mL (7.32 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.